These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34078222)
1. A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the Zhai H; Zheng Y; He Y; Zhang Y; Guo Z; Cui W; Sun L Int J Neurosci; 2023 May; 133(5):574-577. PubMed ID: 34078222 [No Abstract] [Full Text] [Related]
3. Brain dopamine-serotonin vesicular transport disease and its treatment. Rilstone JJ; Alkhater RA; Minassian BA N Engl J Med; 2013 Feb; 368(6):543-50. PubMed ID: 23363473 [TBL] [Abstract][Full Text] [Related]
4. Exome sequencing results in identification and treatment of brain dopamine-serotonin vesicular transport disease. Rath M; Korenke GC; Najm J; Hoffmann GF; Hagendorff A; Strom TM; Felbor U J Neurol Sci; 2017 Aug; 379():296-297. PubMed ID: 28716265 [No Abstract] [Full Text] [Related]
5. Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder. Jacobsen JC; Wilson C; Cunningham V; Glamuzina E; Prosser DO; Love DR; Burgess T; Taylor J; Swan B; Hill R; Robertson SP; Snell RG; Lehnert K J Inherit Metab Dis; 2016 Mar; 39(2):305-8. PubMed ID: 26497564 [TBL] [Abstract][Full Text] [Related]
6. Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2. Kaasalainen S; Arikka H; Martikainen MH; Kaasinen V Case Rep Neurol Med; 2024; 2024():4767647. PubMed ID: 38716424 [TBL] [Abstract][Full Text] [Related]
7. What is new for monoamine neurotransmitter disorders? Marecos C; Ng J; Kurian MA J Inherit Metab Dis; 2014 Jul; 37(4):619-26. PubMed ID: 24696406 [TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933 [TBL] [Abstract][Full Text] [Related]
9. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Lohr KM; Bernstein AI; Stout KA; Dunn AR; Lazo CR; Alter SP; Wang M; Li Y; Fan X; Hess EJ; Yi H; Vecchio LM; Goldstein DS; Guillot TS; Salahpour A; Miller GW Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9977-82. PubMed ID: 24979780 [TBL] [Abstract][Full Text] [Related]
10. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296 [TBL] [Abstract][Full Text] [Related]
11. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
12. Modelling brain dopamine-serotonin vesicular transport disease in Young AT; Ly KN; Wilson C; Lehnert K; Snell RG; Reid SJ; Jacobsen JC Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266839 [TBL] [Abstract][Full Text] [Related]
19. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Glatt CE; Wahner AD; White DJ; Ruiz-Linares A; Ritz B Hum Mol Genet; 2006 Jan; 15(2):299-305. PubMed ID: 16339215 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of P387L mutation in SLC18A2 gene in sporadic Parkinson's disease in Chinese Han population. Kang J; Tang B; Li K; Liu Z; Yan X; Guo J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):825-8. PubMed ID: 26333488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]